INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,430 Cr | ₹2,178 Cr | ₹1,714 Cr | ₹1,579 Cr | ₹1,334 Cr |
What is the latest Total Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,430 Cr |
| Mar2024 | ₹2,178 Cr |
| Mar2023 | ₹1,714 Cr |
| Mar2022 | ₹1,579 Cr |
| Mar2021 | ₹1,334 Cr |
How is Total Liabilities of INDOCO REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,430 Cr | 11.59 | |
| Mar2024 | ₹2,178 Cr | 27.03 | |
| Mar2023 | ₹1,714 Cr | 8.55 | |
| Mar2022 | ₹1,579 Cr | 18.37 | |
| Mar2021 | ₹1,334 Cr | - | |
Compare Total Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,811.8 Cr | 1.2% | -4.2% | -14.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 1.2% |
-4.2% |
-14.9% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses